Literature DB >> 32141339

Exosomes derived from miR-544-modified mesenchymal stem cells promote recovery after spinal cord injury.

Chenggang Li1, Xiao Li2, Bichun Zhao2, Chunfang Wang2.   

Abstract

Recent evidence has demonstrated that exosomes derived from mesenchymal stem cells (MSCs) may serve as a reservoir of miRNAs conferring protection from certain diseases. Hence, the current study was performed with the aim of investigating whether MSCs-exosomal miR-544 could exert protection against spinal cord injury (SCI). In the present study, bone mesenchymal stem cells (BMSCs) isolated from rat bone marrows were transfected with miR-544 mimic. The miR-544-overexpressing BMSCs-derived exosomes (BMSC-Exo) were intravenously injected into SCI model rats. Neurological function, histopathological changes, and the release of inflammatory cytokines were further examined. Results showed that BMSCs-exosomal miR-544 mitigated neural functional recovery after SCI. Moreover, overexpression of miR-544 in BMSC-Exo abated histologic deficits and neuronal loss caused by SCI. Notably, this therapeutic intervention also reduced inflammation following SCI. In conclusion, exosomes derived from miR-544-overexpressing BMSCs improved functional recovery and promoted neuronal survival by attenuating inflammation after SCI.

Entities:  

Keywords:  Exosomes; mesenchymal stem cells; miR-544; spinal cord injury

Mesh:

Substances:

Year:  2020        PMID: 32141339     DOI: 10.1080/13813455.2019.1691601

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  16 in total

Review 1.  Gene-Modified Stem Cells for Spinal Cord Injury: a Promising Better Alternative Therapy.

Authors:  Yirui Feng; Yu Li; Ping-Ping Shen; Bin Wang
Journal:  Stem Cell Rev Rep       Date:  2022-05-19       Impact factor: 5.739

2.  miRNA Therapy in Laboratory Models of Acute Spinal Cord Injury in Rodents: A Meta-analysis.

Authors:  Yang Wang; Hanxiao Yi; Yancheng Song
Journal:  Cell Mol Neurobiol       Date:  2022-06-01       Impact factor: 5.046

Review 3.  Extracellular vesicles as bioactive nanotherapeutics: An emerging paradigm for regenerative medicine.

Authors:  Min Li; Fang Fang; Meng Sun; Yinfeng Zhang; Min Hu; Jinfeng Zhang
Journal:  Theranostics       Date:  2022-06-21       Impact factor: 11.600

Review 4.  The role of miRNAs from mesenchymal stem/stromal cells-derived extracellular vesicles in neurological disorders.

Authors:  Morteza Jafarinia; Majid Reza Farrokhi; Mazdak Ganjalikhani Hakemi; William C Cho
Journal:  Hum Cell       Date:  2022-10-19       Impact factor: 4.374

5.  miR-544-3p mediates arthritis pain through regulation of FcγRI.

Authors:  Yan Liu; Sang-Min Jeon; Michael J Caterina; Lintao Qu
Journal:  Pain       Date:  2021-11-12       Impact factor: 7.926

Review 6.  The Importance of Using Exosome-Loaded miRNA for the Treatment of Spinal Cord Injury.

Authors:  Yunpeng Shen; Junying Cai
Journal:  Mol Neurobiol       Date:  2022-10-24       Impact factor: 5.682

7.  Exosomes secreted from sonic hedgehog-modified bone mesenchymal stem cells facilitate the repair of rat spinal cord injuries.

Authors:  Yijia Jia; Tingsheng Lu; Qiling Chen; Xingwei Pu; Linsong Ji; Jianwen Yang; Chunshan Luo
Journal:  Acta Neurochir (Wien)       Date:  2021-04-05       Impact factor: 2.816

8.  Stem Cell Therapy for Spinal Cord Injury.

Authors:  Liyi Huang; Chenying Fu; Feng Xiong; Chengqi He; Quan Wei
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 9.  Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury.

Authors:  Wen-Zhao Liu; Zhan-Jun Ma; Jie-Ru Li; Xue-Wen Kang
Journal:  Stem Cell Res Ther       Date:  2021-02-03       Impact factor: 6.832

Review 10.  MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies.

Authors:  Andrea Diana; Giuseppe Gaido; Cristina Maxia; Daniela Murtas
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.